Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...

If President Donald Trump imposes drug tariffs that affect the cheap generic medicines Teva Pharmaceutical Industries makes, ...

AUSTEDO® – shows continued strong growth, with worldwide revenues of $411 million in Q1 2025, an increase of 39% in local currency terms compared to Q1 2024; increasing 2025 full-year revenue outlook ...

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple ...